ArticleJVS-vascular science2025
Micro- and nanoplastics are elevated in femoral atherosclerotic plaques compared with undiseased arteries.
Article in JVS-vascular science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Polyethylene Microplastics and Cardiometabolic Mitochondrial-Redox Dysfunction in Preclinical Rodent Models: A Systematic Review and Meta-Analysis of Bioenergetic and Oxidative Stress Outcomes Across Target Organs.Cardiovascular toxicology · 2026Pooled it
- Micro- and nanoplastics in human biological materials: a systematic review of detection methods and methodological challenges.Archives of toxicology · 2026Pooled it
- Micro- and Nanoplastics in Cardiovascular Toxicology: Human Tissue Detection, Clinical Phenotypes, and Adverse Outcome Signals.Cardiovascular toxicology · 2026Review
- Micro- and Nanoplastics as Emerging Cardiovascular Risk Factors: A Systematic Review.Journal of xenobiotics · 2026Review
- Prenatal and Lactational Exposure to Polystyrene Nanoplastics Induces Lipid Accumulation in Vascular Smooth Muscle Cells of Male Offspring via the MAPK/ERK/UHRF1 Signaling Pathway.Cardiovascular toxicology · 2026Article
- Microplastics inhibit macrophage bioenergetics impairing homeostatic function and immune responsiveness.bioRxiv : the preprint server for biology · 2026Article
- Microplastics and Nanoplastics in Cardiovascular Disease: An Emerging Cardiovascular Risk Factor.Cardiovascular toxicology · 2026Review
- A perspective on the future of heart failure research.Journal of molecular and cellular cardiology plus · 2026Article
- Emerging cardiovascular risks of micro- and nanoplastics: toxic effects and mechanistic pathways.Particle and fibre toxicology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: As plastic production continues to accelerate, the byproducts increasingly fill the environment. Once degraded into micronanoplastics (MNPs), particles may circulate into food, drinking water, or air. Nascent literature has demonstrated MNP bioaccumulation within human tissues, such as the blood, brain, and solid organs. Only recently have MNPs been identified within thrombi and atherosclerotic plaques of diseased blood vessels, and these findings have been associated with adverse clinical outcomes. Data on MNP content in infrainguinal arterial occlusive disease is currently lacking, however. We investigated MNP presence within femoral artery plaques and examined patient clinical variables to characterize their associations in a territory commonly affected by peripheral arterial disease. Methods: Common femoral artery plaques were collected from patients undergoing common femoral endarterectomy for medically refractory lower extremity peripheral arterial disease. These samples were then sectioned, frozen, and analyzed using pyrolysis gas chromatography/mass spectrometry for MNP content by polymer. A total of 12 polymers were investigated in triplicate. A group of decedent patients without clinical atherosclerosis served as control with whole carotid artery tissue used for a similar analysis. Results: A total of 10 plaques from 8 patients were collected for the plaque group, and 30 whole carotids were gathered from decedents and age matched to the plaque group. The total MNP concentration was 80-fold higher in femoral plaque compared with the control group 3234 μg/g tissue vs 40.68 μg/g tissue for control arteries ( Conclusions: This study demonstrates a greater accumulation of MNPs in common femoral artery plaques compared with nonatherosclerotic artery tissue. This finding further supports the premise that, despite similarities in age between groups, MNPs tend to be represented heavily in atherosclerotic tissues. Patients with chronic limb-threatening ischemia showed a greater concentration of some polymers compared with those with claudication, raising the question of differential disease severity associations with different individual polymers. Clinical Relevance: This work demonstrates high levels of micronanoplastics (MNPs) in human femoral artery atherosclerotic plaques as compared with healthy, nondiseased human carotid arteries. No clear associations between age and MNP levels were demonstrated amongst limb ischemia or control patients. Some individual polymers are associated with advanced atherosclerotic disease (chronic limb-threatening ischemia) compared with claudication. These data add to the growing literature suggesting that MNP particles accumulate in atherosclerotic lesions. Future work should investigate what mechanistic role, if any, MNPs may play in the pathophysiology of vascular atherosclerotic disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.